U. Michigan launches DNA diagnostic nonprofit; Varian and Intuitive Surgical spar over market share;

 @FierceMedDev: Is Boston Sci still reeling from its $28B purchase of Guidant? More | Follow @FierceMedDev

 @MarkHFierce: Mission accomplished: Sunshine Heart closes public offering of common stock and pulls in $18 million. Item | Follow @MarkHFierce

 @DamianFierce: Regulus has signed on with Biogen Idec to develop microRNA diagnostics for MS. News | Follow @DamianFierce

> The University of Michigan has partnered with the International Genomics Consortium to develop a nonprofit joint venture to develop DNA diagnostics and pursue personalized medicine. More

> Thermo Fisher Scientific ($TMO) is selling debt to help fund its $925 million deal to buy diagnostics firm One Lambda, an acquisition announced last month. News

> Poiesis Medical is launching the Duette urinary catheter, a device it says reduces the risk of bladder trauma present in competing techs. Item

> Alfa Wassermann is now marketing its ACE Axcel clinical chemistry system, a diagnostic interface designed to speed up in-office lab testing. Story

> The battle for market share in robot-assisted surgeries puts Varian Medical ($VAR) against Intuitive Surgical ($ISRG). Article

> Cardiorespiratory diagnostics company Angeion is changing its name and stock symbol. From here on, the firm is called MGC Diagnostics Corporation and trades under $MGCD. Release

Biotech News

 @FierceBiotech: IMS bags planning tech for clinical trials with TTC buyout. News | Follow @FierceBiotech

 @JohnCFierce: Idenix shares eviscerated as clinical hold raises tox fears. Article | Follow @JohnCFierce

 @RyanMFierce: I'm planning a trip to visit my biotech neighbors to the north in Montreal. Looking forward to putting faces to names and so forth. | Follow @RyanMFierce

> Novartis eye drug prevails in PhIII trials ahead of FDA action. News

> Upbeat PhIII results bolster Medivation's big plans for enzalutamide. Story

> Regulus notches another microRNA deal in pact with Biogen Idec. More

> Promising colitis data build blockbuster case for Pfizer's tofacitinib. Story

Pharma News

 @FiercePharma: Maybe K-V Pharma should have listened to Facebook as the Makena pricing furor grew: More | Follow @FiercePharma

> Guess who's coming to dinner, Howard? More

> Abbott's CEO paycheck bigger than its tax bill, study says. Article

> U.K. docs don't see sales reps, and don't use pharma's websites, either. News

Vaccines News

> Antigen Discovery receives $2.5M grant for malaria vax. Item

> Heart disease vaccine steps closer. Report

> Feds cut Ebola vax funding. More

> FDA approves 6 flu vaccines. Story

Pharma Manufacturing News

> It is overfilled pain drug in latest Hospira recall. News

> Morphotek turns to manufacturing with new plant. Story

> West-Ward plant problems undermine Hikma earnings. Article

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.